Chinook Therapeutics Obtains Worldwide Rights from AbbVie to Atrasentan with Plans to Develop for the Treatment of Kidney Diseases
VANCOUVER, British Columbia–(BUSINESS WIRE)–Chinook Therapeutics, Inc., a biotechnology company focused on developing precision medicines for